Literature DB >> 3609054

Myocardial scintigraphy with I-123 heptadecanoic acid as a test for coronary heart disease.

R Railton, J C Rodger, D R Small, A D Harrower.   

Abstract

We have evaluated 123I-heptadecanoic acid for myocardial scintigraphy in the diagnosis of coronary heart disease by comparing the results obtained with it in subject groups with high and low probabilities of disease. We conclude that although some patients in the former group can be identified, the test is neither sufficiently sensitive nor specific for routine clinical use.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3609054     DOI： 10.1007/bf00256017

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  9 in total

1.  Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia.

Authors:  L H Opie
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

2.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease.

Authors:  G A Diamond; J S Forrester
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

3.  Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201.

Authors:  J Maddahi; E V Garcia; D S Berman; A Waxman; H J Swan; J Forrester
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

4.  Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris.

Authors:  E E van der Wall; G A Heidendal; W den Hollander; G Westera; J P Roos
Journal:  Eur J Nucl Med       Date:  1981

5.  Spatial and temporal quantitation of plane thallium myocardial images.

Authors:  D D Watson; N P Campbell; E K Read; R S Gibson; C D Teates; G A Beller
Journal:  J Nucl Med       Date:  1981-07       Impact factor: 10.057

6.  Metabolic fate of radioiodinated heptadecanoic acid in the normal canine heart.

Authors:  F C Visser; M J van Eenige; G Westera; W Den Hollander; C M Duwel; E E van der Wall; G A Heidendal; J P Roos
Journal:  Circulation       Date:  1985-09       Impact factor: 29.690

7.  Exercise thallium-201 myocardial imaging in left main coronary artery disease: sensitive but not specific.

Authors:  T Rehn; L S Griffith; S C Achuff; I K Bailey; B H Bulkley; R Burow; B Pitt; L C Becker
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

8.  Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid.

Authors:  C Freundlieb; A Höck; K Vyska; L E Feinendegen; H J Machulla; G Stöcklin
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

9.  Free fatty acid metabolism of the human heart at rest.

Authors:  A S Most; N Brachfeld; R Gorlin; J Wahren
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808
  9 in total
  3 in total

Review 1.  Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives.

Authors:  F F Knapp; J Kropp
Journal:  Eur J Nucl Med       Date:  1995-04

Review 2.  Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.

Authors:  R Valkema; B L van Eck-Smit; E E van der Wall
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

3.  Comparison of 16-iodohexadecanoic acid (IHDA) and 15-p-iodophenylpentadecanoic acid (IPPA) metabolism and kinetics in the isolated rat heart.

Authors:  T R DeGrado; J E Holden; C K Ng; D M Raffel; S J Gatley
Journal:  Eur J Nucl Med       Date:  1988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.